Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Sarveshwar Foods Ltd
| Quarterly Financial Results Q3 FY 2025-26
Summary : Sarveshwar Foods Limited reported strong consolidated and standalone financial results for Q3/9M FY26, with significant revenue and profit growth, and successful rights issue allotment.
Quarterly Report Analysis & Insights
Financial Disclosures
- Consolidated Total Expenses (9 months ended 31.12.2025): INR 93,372.02 Lakhs.
- Standalone Total Expenses (9 months ended 31.12.2025): INR 45,290.83 Lakhs.
- Consolidated Cost of Material Consumed (9 months ended 31.12.2025): INR 30,002.98 Lakhs.
- Consolidated Purchase of stock-in-trade (9 months ended 31.12.2025): INR 49,714.74 Lakhs.
- Consolidated Revenue from Operations (9 months ended 31.12.2025): INR 96,298.32 Lakhs.
- Standalone Revenue from Operations (9 months ended 31.12.2025): INR 46,395.69 Lakhs.
- Consolidated Domestic Revenue (9 months ended 31.12.2025): INR 91,092.18 Lakhs.
- Consolidated Export Revenue (9 months ended 31.12.2025): INR 5,206.14 Lakhs.
- Consolidated Paid up share capital (31.12.2025): INR 12,287.26 Lakhs.
- Standalone Paid up share capital (31.12.2025): INR 12,287.26 Lakhs.
- Both standalone and consolidated unaudited financial results are presented.
- Consolidated entities include Sarveshwar Overseas, Himalayan Bio Organic Foods, Green Point PTE, Natural Global Foods DMCC, and Himalayan Ancient Foods Private Limited.
Corporate Overview
- Domestic
- Export
- The company's business is solely dependent on the processing and trading of rice.
- The company's primary business segment is processing and trading of rice.
- Formal and compliant with regulatory disclosure requirements.
- Processing and trading of rice.
- Monitoring Agency Report for Rights Issue of shares indicates capital raising for potential expansion.
Risk Factors
- Single business segment dependency.
- Fluctuating raw material costs.
- Intense competition in food sector.
- Regulatory changes in Indian market.
Key Drivers
- Strong revenue growth year-over-year.
- Increased profitability for the period.
- Successful rights issue allotment.
- International market expansion via subsidiaries.
Auditor’s Report
- Unmodified review conclusion on unaudited financial results.
- Not applicable for a review report, as no audit opinion is expressed.
Board Commentary
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Compliance with Section 133 of the Companies Act, 2013.
- Consideration and approval of Monitoring Agency Report for Rights Issue of shares allotted on 17th September 2025.
Corporate Governance
- Financial results reviewed by Audit Committee and approved by the Board of Directors.
- Audit Committee is in place and active in reviewing financial results.